The approval was based on Part 1 (72 week data) of the randomized, double-blind, placebo-controlled phase 3 ESSENCE trial.

The Food and Drug Administration (FDA) has granted Orphan Drug designation to dusquetide (SGX945) for the treatment of Behçet disease, a type of vasculitis characterized by mucocutaneous symptoms (eg, ...

Imagined speech signals were weaker than attempted speech but still accurate enough to reach up to 74% recognition in real time.

Zopapogene imadenovec is a non-replicating adenoviral vector-based immunotherapy designed to induce an immune response against HPV 6 and HPV 11 proteins.

FluMist is delivered in a temperature-controlled package with at-home specific instructions on the proper handling, administration, and disposal of the vaccine.

Nerve stimulation device cleared for sleep apnea; Skysona safety update; new non-cystic fibrosis bronchiectasis treatment; FDA cracks down on animal-derived thyroid meds; RSV therapy to be ...

The updated recommendations also address the link between high blood pressure and cognitive decline and dementia.

Treatment linked to reduced rates of first occurrence of suicidal behaviors, substance misuse, transport accidents, criminality.

Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured.

Thirty-four point three and 37.6% of US adults were reportedly unaware of HPV and lacked awareness about the HPV vaccine, respectively.

The sodium chloride 0.9% injection shortage is resolved, and it will be removed from the FDA Drug Shortage Database; facilities are advised to use FDA-approved products when available. The FDA is ...

Future prospective studies will be necessary to assess potential causation of sucralose in driving immunotherapy resistance as well as to determine how other demographic factors, including location ...